Ipswich Investment Management’s Labcorp LH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $321K | Hold |
1,145
| – | – | 0.07% | 149 |
|
|
2026
Q1 | $305K | Hold |
1,145
| – | – | 0.07% | 152 |
|
|
2025
Q4 | $287K | Hold |
1,145
| – | – | 0.07% | 150 |
|
|
2025
Q3 | $329K | Hold |
1,145
| – | – | 0.08% | 141 |
|
|
2025
Q2 | $301K | Sell |
1,145
-75
| -6% | -$18.3K | 0.07% | 151 |
|
|
2025
Q1 | $284K | Hold |
1,220
| – | – | 0.07% | 157 |
|
|
2024
Q4 | $280K | Sell |
1,220
-200
| -14% | -$45.9K | 0.07% | 161 |
|
|
2024
Q3 | $317K | Hold |
1,420
| – | – | 0.07% | 156 |
|
|
2024
Q2 | $289K | Sell |
1,420
-190
| -12% | -$38.6K | 0.07% | 159 |
|
|
2024
Q1 | $352K | Hold |
1,610
| – | – | 0.08% | 148 |
|
|
2023
Q4 | $366K | Hold |
1,610
| – | – | 0.09% | 139 |
|
|
2023
Q3 | $324K | Sell |
1,610
-264
| -14% | -$55.7K | 0.09% | 145 |
|
|
2023
Q2 | $389K | Hold |
1,874
| – | – | 0.1% | 138 |
|
|
2023
Q1 | $369K | Sell |
1,874
-18
| -1% | -$3.7K | 0.1% | 140 |
|
|
2022
Q4 | $383K | Hold |
1,892
| – | – | 0.11% | 136 |
|
|
2022
Q3 | $333K | Sell |
1,892
-582
| -24% | -$119K | 0.11% | 138 |
|
|
2022
Q2 | $498K | Hold |
2,474
| – | – | 0.14% | 120 |
|
|
2022
Q1 | $560K | Hold |
2,474
| – | – | 0.14% | 122 |
|
|
2021
Q4 | $668K | Hold |
2,474
| – | – | 0.16% | 114 |
|
|
2021
Q3 | $598K | Hold |
2,474
| – | – | 0.15% | 118 |
|
|
2021
Q2 | $586K | Hold |
2,474
| – | – | 0.15% | 122 |
|
|
2021
Q1 | $542K | Hold |
2,474
| – | – | 0.15% | 113 |
|
|
2020
Q4 | $433K | Hold |
2,474
| – | – | 0.13% | 122 |
|
|
2020
Q3 | $400K | Sell |
2,474
-98
| -4% | -$15.5K | 0.13% | 121 |
|
|
2020
Q2 | $367K | Sell |
2,572
-291
| -10% | -$40.3K | 0.13% | 123 |
|
|
2020
Q1 | $311K | Hold |
2,863
| – | – | 0.12% | 126 |
|
|
2019
Q4 | $416K | Sell |
2,863
-59
| -2% | -$8.52K | 0.12% | 133 |
|
|
2019
Q3 | $422K | Sell |
2,922
-87
| -3% | -$12.7K | 0.13% | 129 |
|
|
2019
Q2 | $447K | Hold |
3,009
| – | – | 0.14% | 124 |
|
|
2019
Q1 | $395K | Sell |
3,009
-192
| -6% | -$23.7K | 0.13% | 129 |
|
|
2018
Q4 | $347K | Hold |
3,201
| – | – | 0.13% | 125 |
|
|
2018
Q3 | $478K | Sell |
3,201
-12,259
| -79% | -$1.86M | 0.16% | 115 |
|
|
2018
Q2 | $2.38M | Sell |
15,460
-1,735
| -10% | -$262K | 1.1% | 35 |
|
|
2018
Q1 | $2.39M | Buy |
17,195
+210
| +1% | +$30.8K | 1.01% | 32 |
|
|
2017
Q4 | $2.33M | Buy |
16,985
+303
| +2% | +$40K | 0.99% | 31 |
|
|
2017
Q3 | $2.16M | Sell |
16,682
-64
| -0.4% | -$8.54K | 0.97% | 34 |
|
|
2017
Q2 | $2.22M | Sell |
16,746
-5,512
| -25% | -$675K | 1.04% | 34 |
|
|
2017
Q1 | $2.74M | Buy |
22,258
+1,059
| +5% | +$125K | 1.2% | 31 |
|
|
2016
Q4 | $2.34M | Buy |
21,199
+2,229
| +12% | +$248K | 1.06% | 35 |
|
|
2016
Q3 | $2.24M | Buy |
18,970
+3,620
| +24% | +$427K | 1.1% | 37 |
|
|
2016
Q2 | $1.72M | Buy |
15,350
+1,543
| +11% | +$166K | 0.85% | 42 |
|
|
2016
Q1 | $1.48M | Buy |
+13,807
| New | +$1.32M | 0.71% | 49 |
|
Other funds holding LH
RRAM
AAM
DIA
SFA
WCM
HPCM
MCM
BHIA
Ipswich Investment Management's LH Position: Q2 2026 in Review
Ipswich Investment Management held its Labcorp (LH) position steady in Q2 2026 at 1,145 shares worth $321K. The position accounts for 0.07% of the portfolio, ranked #149.
Ipswich Investment Management first reported a position in LH in Q1 2016 and has held it in 42 quarters since. The position peaked at $2.74M in Q1 2017. 215 funds tracked by Wall St. Rank hold LH as of Q2 2026.
- Ipswich Investment Management held 1,145 shares of Labcorp worth $321K as of Q2 2026.
- Ipswich Investment Management left its Labcorp share count unchanged in Q2 2026.
- Labcorp made up 0.07% of Ipswich Investment Management's portfolio in Q2 2026, its #149 holding.
- Ipswich Investment Management first reported a position in Labcorp in Q1 2016 and has held it in 42 quarters since.
- Ipswich Investment Management's Labcorp position peaked at $2.74M in Q1 2017.
- 215 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.
Based on Ipswich Investment Management's 13F filing for Q2 2026, filed 16 Jul 2026.